All News

The recently published findings may open new avenues for treating urinary tract infections.

The authors of a recently published study have found that bariatric surgery may provide a significant benefit beyond dramatic weight loss.

New findings based on pharmacy claims data show just how adherent patients are to a thiazide, alkali citrate, and allopurinol.

A large, randomized trial provides a head-to-head comparison of late complications involving the two approaches to BPH.

New study data suggest an answer to the problem of managing stones in pregnant women.

Study findings suggest that high levels of vitamin D could be harmful to the prostate.

Urologist Stephen G. Weiss II, MD, FACS, explains why he is voluntarily relinquishing his American Board of Urology certificate.

Urology Times blogger Henry Rosevear, MD, got reactions to an earlier blog about falls in the elderly-but not from who he was expecting to hear from.

The first clinical trial of a novel ultrasound technology shows that it can safely reposition stones in situ to make them more amenable to natural passage and treatment.

With several years now passing since the USPSTF issued its grade D recommendation discouraging PSA-based prostate cancer screening, researchers are reporting conflicting findings on its impact on clinical practice.

We are entering a new era when patients will present not with an elevated PSA but rather with symptoms, writes Henry Rosevear, MD.

The Independent Payment Review Board appears to be headed out of existence, much to the pleasure of much of the provider community-including urologists.

When anticipating a divorce, it’s important to understand there are often major financial consequences and some important tax issues that need to be addressed.

In this article, we describe the use of morphological market research to identify six themes or modes that shape men’s health behaviors and how those modes can be ultimately used to improve men’s health.

In this article, Nick van Terheyden, MD (aka “Dr. Nick”), explains why you need to be active on social media and how to get started.

In this column, Ray Painter, MD, and Mark Painter also answer questions about coding for bladder hydrodistention under moderate sedation and re-positioning of a ureteral stent by a radiologist.

“The FDA is being very cautious, which as the protector of public health, it’s got to be," says one urologist.

Urology Times’ “Best of AUA 2015” report provides a guide to the meeting’s take-home messages in 15 therapeutic areas-an information-packed, condensed summary of the top papers and presentations.

The Affordable Care Act has survived its latest legal challenge. After reading the Supreme Court's recent decision in King v. Burwell, Dan Shaffer of the AACU discusses how the justices arrived at it and what it means to you.

Active surveillance for men with low-risk prostate cancer has made it to prime time. That was the message of Stacy Loeb, MD, who moderated a press conference at the AUA annual meeting, where four studies documented the increasing popularity and safety of active surveillance in managing low-risk disease.

Antimicrobial prescription, imaging for localized prostate cancer, and shared decision making for PSA screening are among the topics of the AUA’s latest Choosing Wisely recommendations.

Urology Times has appointed three expert urologists to its Editorial Council.

A two-drug treatment regimen works better than monotherapy for incontinent overactive bladder patients, researchers reported at the AUA annual meeting in New Orleans.

Chemicals in green tea may help inhibit development of prostate cancer in men at high risk, according to results of a randomized, controlled trial.

Use of mesh in the treatment of pelvic organ prolapse is increasing, despite FDA warnings about its risks.

The survival benefit associated with high-dose IL-2 in metastatic renal cell carcinoma may be better than previously believed.

An experimental assay could reduce the need for prostate needle biopsies, researchers say.

In a phase III study, a drug that blocks production of a protein was associated with a 27% reduction in the risk of death.